Tenvir-EM Tablet is a fixed-dose combination medication used primarily for the treatment of HIV-1 infection. It contains two active ingredients such as Tenofovir Disoproxil Fumarate and Emtricitabine.

Brand Name: Tenvir-EM

Composition: Tenofovir Disoproxil Fumarate, Emtricitabine

Mechanism of Action:

The reverse transcriptase enzyme is inhibited by tenofovir and emtricitabine, which stops viral RNA from being converted to DNA and stops the virus from multiplying inside the host cells. By lowering the blood's viral load, this dual action strengthens the immune system and lowers the risk of consequences from HIV.

Uses:

HIV-1 Infection

Dosage and Administration:

One tablet taken once a day, with or without food, is the usual dosage.

Side Effects:

• Fatigue
• Headache
• Nausea
• Vomiting
• Fever
• Cough
• Insomnia
• Liver Function Abnormalities
• Allergic Reactions

Safety Advise:

Kidney  

Monitor kidney function regularly, as Tenvir-EM can cause nephrotoxicity. Kindly speak with your healthcare provider.

Liver  

Monitor liver function regularly, as Tenvir-EM can cause liver impairement. Kindly speak with your healthcare provider.

Pregnancy  

Tenvir-EM should be used during pregnancy only if clearly needed, Kindly speak with your healthcare provider.

Breast Feeding  

Using Tenvir-EM while nursing is most likely dangerous. Kindly speak with your healthcare provider.

Alcohol  

Tenvir-EM should not be taken with alcohol. Kindly speak with your healthcare provider.

Storage:

Store Tenvir-EM Tablet at a temperature between 15°C and 30°C (59°F to 86°F). Keep the tablets in the original packaging to protect them from light and moisture. Keep out of reach of children.

How to use this Medication?

Drink a glass of water along with this prescription. Take it daily at the same time as specified on the prescription label. Consume it with food. Take each dose exactly as directed on the prescription label for the best potential outcome from your therapy. Don't miss any dosages. The virus may become resistant to this and other medications if doses are skipped. Unless instructed otherwise by your care team, continue taking this therapy.

Discuss the usage of this drug in children with your care team. For certain illnesses, it can be administered to youngsters as young as 12, although there are safety precautions to take.

References:

1.   Arribas JR, Pozniak AL, Gallant JE, DeJesus E, Gazzard B, Campo RE, Chen SS, McColl D, Holmes CB, Enejosa J, Toole JJ. Tenofovir disoproxil fumarate, emtricitabine, and efavirenz compared with zidovudine/lamivudine and efavirenz in treatment-naive patients: 144-week analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2008 Jan 1;47(1):74-8.

2.  Pozniak AL, Gallant JE, DeJesus E, Arribas JR, Gazzard B, Campo RE, Chen SS, McColl D, Enejosa J, Toole JJ, Cheng AK. Tenofovir disoproxil fumarate, emtricitabine, and efavirenz versus fixed-dose zidovudine/lamivudine and efavirenz in antiretroviral-naive patients: virologic, immunologic, and morphologic changes-a 96-week analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2006 Dec 15;43(5):535-40.

Disclaimer:

The main goal of Apothecare Wellness is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Wellness, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.

Marketer details

Name: Cipla Ltd

Address: Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Country of origin: India